James Ferriss

Assistant Professor

20092019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where James Ferriss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Endometrioid Carcinoma Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

Endometrial Neoplasms
Lymph Node Excision

Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer

Tewari, K. S., Burger, R. A., Enserro, D., Norquist, B. M., Swisher, E. M., Brady, M. F., Bookman, M. A., Fleming, G. F., Huang, H., Homesley, H. D., Fowler, J. M., Greer, B. E., Boente, M., Liang, S. X., Ye, C., Bais, C., Randall, L. M., Chan, J. K., Stuart Ferriss, J., Coleman, R. L. & 7 others, Aghajanian, C., Herzog, T. J., DiSaia, P. J., Copeland, L. J., Mannel, R. S., Birrer, M. J. & Monk, B. J., Sep 10 2019, In : Journal of Clinical Oncology. 37, 26, p. 2317-2328 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Survival
Recombinational DNA Repair
Therapeutics
Maintenance

Immunotherapy: Checkpoint Inhibitors in Lynch-Associated Gynecologic Cancers

Ferriss, J. S. & Williams-Brown, M. Y., Oct 1 2019, In : Current treatment options in oncology. 20, 10, 75.

Research output: Contribution to journalReview article

Immunotherapy
Immune System
Neoplasms
Tumor Microenvironment
Therapeutics

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Ovarian Neoplasms
Placebos
Disease-Free Survival

Blood loss from robotic assisted hysterectomy

Jordan, S. E., Stone, D., Yu, D., Ferriss, J. S., Hernandez, E. & Rubin, S., Apr 2017, In : Journal of Gynecologic Surgery. 33, 2, p. 47-50 4 p.

Research output: Contribution to journalArticle

Robotics
Hysterectomy
Hemoglobins
Blood Transfusion
Laparotomy